Pharmacotherapy of childhood anxiety disorders.

Christopher J Kratochvil, Martin J. Harrington, William J. Burke, John S. March

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Anxiety disorders are among the most common psychiatric disorders of childhood, yet limited data is available regarding the use of psychotropic medications for these conditions. Until recently, much of the data on the pharmacologic treatment of pediatric anxiety disorders has consisted of case reports and small open-label studies, with the exception of pediatric obsessive-compulsive disorder (OCD), which has had a comparatively rich literature consisting of several double blind trials. This void has been lessening, however, with four double blind, placebo-controlled studies published in the past year alone. Although the majority of pharmacologic studies of pediatric anxiety continue to focus on the treatment of OCD, additional reports on treatment of generalized anxiety disorder, panic disorder, social anxiety disorder, and separation anxiety disorder have recently been published. This article will review significant pharmacologic studies published in the prior year, and the role of pharmacotherapy in the treatment of pediatric anxiety disorders.

Original languageEnglish (US)
Pages (from-to)264-269
Number of pages6
JournalCurrent psychiatry reports
Volume4
Issue number4
DOIs
StatePublished - Jan 1 2002

Fingerprint

Anxiety Disorders
Pediatrics
Drug Therapy
Obsessive-Compulsive Disorder
Separation Anxiety
Panic Disorder
Therapeutics
Psychiatry
Anxiety
Placebos

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Pharmacotherapy of childhood anxiety disorders. / Kratochvil, Christopher J; Harrington, Martin J.; Burke, William J.; March, John S.

In: Current psychiatry reports, Vol. 4, No. 4, 01.01.2002, p. 264-269.

Research output: Contribution to journalReview article

Kratochvil, Christopher J ; Harrington, Martin J. ; Burke, William J. ; March, John S. / Pharmacotherapy of childhood anxiety disorders. In: Current psychiatry reports. 2002 ; Vol. 4, No. 4. pp. 264-269.
@article{9416dacb4bb04f28b2e49f3f866212c4,
title = "Pharmacotherapy of childhood anxiety disorders.",
abstract = "Anxiety disorders are among the most common psychiatric disorders of childhood, yet limited data is available regarding the use of psychotropic medications for these conditions. Until recently, much of the data on the pharmacologic treatment of pediatric anxiety disorders has consisted of case reports and small open-label studies, with the exception of pediatric obsessive-compulsive disorder (OCD), which has had a comparatively rich literature consisting of several double blind trials. This void has been lessening, however, with four double blind, placebo-controlled studies published in the past year alone. Although the majority of pharmacologic studies of pediatric anxiety continue to focus on the treatment of OCD, additional reports on treatment of generalized anxiety disorder, panic disorder, social anxiety disorder, and separation anxiety disorder have recently been published. This article will review significant pharmacologic studies published in the prior year, and the role of pharmacotherapy in the treatment of pediatric anxiety disorders.",
author = "Kratochvil, {Christopher J} and Harrington, {Martin J.} and Burke, {William J.} and March, {John S.}",
year = "2002",
month = "1",
day = "1",
doi = "10.1007/s11920-996-0045-8",
language = "English (US)",
volume = "4",
pages = "264--269",
journal = "Current Psychiatry Reports",
issn = "1523-3812",
publisher = "Current Science, Inc.",
number = "4",

}

TY - JOUR

T1 - Pharmacotherapy of childhood anxiety disorders.

AU - Kratochvil, Christopher J

AU - Harrington, Martin J.

AU - Burke, William J.

AU - March, John S.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Anxiety disorders are among the most common psychiatric disorders of childhood, yet limited data is available regarding the use of psychotropic medications for these conditions. Until recently, much of the data on the pharmacologic treatment of pediatric anxiety disorders has consisted of case reports and small open-label studies, with the exception of pediatric obsessive-compulsive disorder (OCD), which has had a comparatively rich literature consisting of several double blind trials. This void has been lessening, however, with four double blind, placebo-controlled studies published in the past year alone. Although the majority of pharmacologic studies of pediatric anxiety continue to focus on the treatment of OCD, additional reports on treatment of generalized anxiety disorder, panic disorder, social anxiety disorder, and separation anxiety disorder have recently been published. This article will review significant pharmacologic studies published in the prior year, and the role of pharmacotherapy in the treatment of pediatric anxiety disorders.

AB - Anxiety disorders are among the most common psychiatric disorders of childhood, yet limited data is available regarding the use of psychotropic medications for these conditions. Until recently, much of the data on the pharmacologic treatment of pediatric anxiety disorders has consisted of case reports and small open-label studies, with the exception of pediatric obsessive-compulsive disorder (OCD), which has had a comparatively rich literature consisting of several double blind trials. This void has been lessening, however, with four double blind, placebo-controlled studies published in the past year alone. Although the majority of pharmacologic studies of pediatric anxiety continue to focus on the treatment of OCD, additional reports on treatment of generalized anxiety disorder, panic disorder, social anxiety disorder, and separation anxiety disorder have recently been published. This article will review significant pharmacologic studies published in the prior year, and the role of pharmacotherapy in the treatment of pediatric anxiety disorders.

UR - http://www.scopus.com/inward/record.url?scp=0036674508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036674508&partnerID=8YFLogxK

U2 - 10.1007/s11920-996-0045-8

DO - 10.1007/s11920-996-0045-8

M3 - Review article

VL - 4

SP - 264

EP - 269

JO - Current Psychiatry Reports

JF - Current Psychiatry Reports

SN - 1523-3812

IS - 4

ER -